Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
161.3 USD | +3.13% | +5.92% | -15.86% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.86% | 19.79B | |
+49.28% | 56.87B | |
+37.15% | 39.72B | |
-5.96% | 39.27B | |
-6.90% | 28.73B | |
+13.23% | 26.21B | |
+32.51% | 12.28B | |
+27.88% | 12.23B | |
+0.73% | 12.12B | |
-9.33% | 10.84B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Oppenheimer Downgrades Alnylam Pharmaceuticals to Perform From Outperform, Removes $249 Price Target